News

As the U.S. Environmental Protection Agency reconsiders the ban on asbestos, an Indiana man suffering from asbestosis ...
Mesothelioma is a rare but almost always fatal form of cancer linked to asbestos exposure. It is predominantly detected among ...
"We’ve known for generations." Health advocates sound alarm as US agency changes course on cancer-causing building material: 'Once again putting lives at risk' first appeared on The Cool Down.
Decades after the U.S. Military used asbestos extensively, indisputable scientific evidence linked this natural mineral with asbestosis, lung cancer, and a rare malignancy occurring in mesothelial ...
Herbs, natural supplements, acupuncture, and a balanced diets are all great to implement during cancer treatment, but they won't necessarily provide a cure. Oncologist share more about the ...
Summary STS is an uncommon type of cancer that starts in soft tissues such as fat, muscle, fibrous tissue, cartilage, blood vessels, lymph vessels, and nerves. Therefore, STS can start in the leg.
“It is Stage 4 metastatic breast cancer that has spread to my bones,” Feller told her followers, adding that she was “overwhelmed" by the diagnosis. "I am up to my eyeballs in cancer admin.
Appendix cancer diagnoses are increasing among younger adults. Learn about symptoms, risk factors, and the importance of early detection in this growing health concern.
Looking at patients in subgroups who were felt to have a poor prognosis based on certain factors: large tumor size, the presence of particular CTNNB mutations, younger age, and the presence of pain at ...
Miss Manners would prefer that any such label be dispensed with altogether. If it comes up in conversation, you simply say that you had cancer, and that now, thankfully, you are doing well. That ...
City of Hope co-led the first study to demonstrate that characterizing genetic material near chromosomes forecasts how mutated, cancer-causing genes reengineer DNA and alter the tumor ...
Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.